Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Antibodies and methods for treating estrogen receptor-associated diseases

Antibodies and methods for treating estrogen receptor-associated diseases

US Patent 10233249 · Granted Mar 19, 2019

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Compounds and methods for the targeted degradation of androgen receptor2025
Combination therapy with a phosphoinositide 3-kinase inhibitor with a zinc bindi2025
Fospropofol formulations2025
Fospropofol methods and compositions2025
Fulvestrant formulations and methods of their use2025
Modulators of BCL6 proteolysis and associated methods of use2025
Antibodies and methods for making and using the same2025
Modulators of estrogen receptor proteolysis and associated methods of use2025
Nanotherapeutic systems and methods using particle-driven photodynamic therapy (2025
Compounds and methods for the enhanced degradation of targeted proteins2025
Cereblon ligands and bifunctional compounds comprising the same2025
Methods of treating breast cancer with tetrahydronaphthalene derivatives as estr2025